ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

Could Coconut Oil Help Reduce Antibiotics?

 
Print Page
Email Article

Promising New Option When Near-Vision Poops Out

  [ 2 votes ]   [ 1 Comment ]
www.ProHealth.com • November 12, 2010


Results of clinical research on new presbyopia treatments now available in Europe – and possibly available soon in the US – were reported Oct 19 at an international ophthalmologist conference in Chicago

Presbyopia is Inevitable

From age 40 onward our eyes' lenses gradually lose the ability to focus on close-up objects, a condition called presbyopia which involves loss of the lens/cornea flexibility needed to switch between near and distance vision. (In Greek, presbyopia means “old eye.”)

By our 50s or 60s, almost everyone experiences blurry near vision, although distance vision often remains good (while near-sighted people experience more blurry distance vision).

More than 60 million people in the United States are presbyotic, as are more than 400 million worldwide. Reading glasses are one solution, but many people are interested in glasses-free vision correction.

Options now available include a type of laser (Lasik) surgery or a contact lense that can improve near vision in one eye, called monovision; and Ben Franklin’s bifocals.

But within a few years, new presbyopia treatments will likely be available in the U.S.

Micro-Lens Implant

Ioannis G. Pallikaris, MD,  University Hospital of Crete, Greece, reported on a new type of micro-lens, the Flexivue,* that was implanted in the corneas of 15 patients, who were followed for 12 months post-surgery.

• In a procedure lasting about 10 minutes, an extremely thin lens was inserted into the cornea (the clear outer structure) of the patient's non-dominant eye through a tiny pocket made with a highly precise femtosecond laser.

• The specific vision-correcting prescription for each patient was incorporated in the outer area of the lens.

• After lens insertion, the pocket self-sealed and held the lens in place.

• On average, treated eye near vision improved from 20/100 to 20/25 without glasses, and distance vision decreased from 20/20 to 20/40.

• Vision remained stable in both eyes post-surgery in all patients through the follow-up period.

"This corneal lens implant appears to be a safe, effective way to correct presbyopia in people aged 45 to 60," said Dr. Pallikaris.

• "98% of patients were satisfied with their vision;

• 69% reported 'excellent' and 30 percent 'good' near vision in our survey;

• 92% said they no longer used glasses."

He said there were no surgery-related complications, but about 15% of patients reported glare and/or halos around lights, and some had reduced contrast sensitivity.

Distance vision in the implanted eye is less influenced and remains better than it would be when a Lasik monovision procedure corrects for near vision. Dr. Pallikaris called this advantage "smart monovision."

Can Be Reversed/Removed

Another key advantage is that, unlike Lasik and related refractive surgical procedures, the effects of corneal lens implants can be reversed by lens removal.

Dr. Pallikaris was one of the pioneers of Lasik in the early 1990s. 

Not For Everyone

He stressed that proper patient selection is crucial to the success of the microlense:

• The candidate should have worn reading glasses for at least one year;

• Patients would be disqualified if they have certain types of astigmatism (an irregularity in the curve of the cornea), lens opacity (cataract) or several other conditions.

___
* Financial disclosure: Dr. Pallikaris states that he is chair of the medical advisory board of Presbia, the company that makes Flexivue.

Source: American Academy of Ophthalmology news release Oct 19, 2010




Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Vitamin D3 Extreme™ Ultra ATP+, Double Strength


Article Comments Post a Comment

eye surgery
Posted by: Pewaukee
Aug 9, 2011
Does anyone know if this procedure can be performed on people who have had lasik

? Preserving vision should be of the highest priority for everyone. I look forward to reading more about this procedure.
Reply Reply
 
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Herbal Rescue for High Blood Sugar Herbal Rescue for High Blood Sugar
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map